Company News

New Study Demonstrates MyoStrain® Ability to Differentiate Between Varying Levels of Left Ventricular Hypertrophy to Help Optimize Therapy
Myocardial Solutions’ software platform, MyoStrain, was featured in a new Journal of Cardiovascular Magnetic Resonance publication evaluating a multiparametric assessment of left ventricular hypertrophy (LVH). LVH, which can be a result of an array of diseases and conditions, makes determining the..
This is some text inside of a div block.
July 22, 2021
New Study Demonstrates MyoStrain® Ability to Detect Subclinical Cardiac Dysfunction in Patients with Wilson Disease
A recent study published in the Journal of Cardiovascular Magnetic Resonance featured Myocardial Solutions’ technology MyoStrain, where MyoStrain was used to examine myocardial tissue function in Wilson Disease (WD) patients. WD, a storage disease that results in...
This is some text inside of a div block.
July 12, 2021
PREFECT Trial Outcomes Demonstrate MyoStrain® Ability to Detect & Predict Early Cardiotoxicity in Cancer Patients Undergoing Chemotherapy
A new pivotal article validated Myocardial Solutions technology MyoStrain® (fSENC) for the early detection and prediction of cardiotoxicity (heart damage). The article was published in published in Circulation: Cardiovascular Imaging, Journal of the American Heart Association–one of the most ...
This is some text inside of a div block.
June 21, 2021
MyoStrain® Provides Rapid, Accurate Assessment to Help Clinicians Detect Myocardial Ischemia and Rule Out Obstructive Coronary Artery Disease in Acute Chest Pain Patients
Myocardial Solutions (“MSI”) technologies MyoStrain® (fSENC) was featured in a newly published article exploring the effectiveness of cardiovascular magnetic resonance (CMR) and segmental strain to detect ischemia in patients suspected of obstructive coronary artery disease (CAD)...
This is some text inside of a div block.
May 13, 2021
MyoStrain®, MyoStress™ Rapid Hyperventilation Breath-hold Maneuver Enables First-of-its-Kind Needle-Free Stress Protocol for the Accurate Detection of Myocardial Ischemia
A new peer-reviewed study accepted in the Journal of the American College of Cardiology: Cardiovascular Imaging validated Myocardial Solutions (“MSI”) technologies MyoStrain and MyoStress in a new stress testing protocol utilizing a hyperventilation breath-hold (HVBH) maneuver to accurately ...
This is some text inside of a div block.
April 28, 2021
1 / 9

Get Email Alerts

Subscribe to the newsletter to receive instant email notifications and alerts when news comes MyoStrain® and Myocardial Solutions, Inc.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.